title: Circulating tumour cells as surrogate biomarkers in castration-resistant prostate cancer trials.
authors.forename: Anders
authors.initials: A
authors.lastname: Bjartell
mesh_terms: D000069501:Abiraterone Acetate; D000730:Androstadienes / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009360:Neoplastic Cells, Circulating / Q000378:metabolism*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D013254:Steroid 17-alpha-Hydroxylase / Q000037:antagonists & inhibitors*
chemical_list: D000730:Androstadienes; D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D004791:Enzyme Inhibitors; D015514:Oncogene Proteins, Fusion; C515553:TMPRSS2-ERG fusion protein, human; C501892:CYP17A1 protein, human; D013254:Steroid 17-alpha-Hydroxylase; D000069501:Abiraterone Acetate